Deschatelets Pascal 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 14, 2025
Insider Transaction Report
Form 4
Deschatelets Pascal
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-01-13$28.70/sh−2,288$65,670→ 1,138,195 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 10, 2025.